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The inhibitor activity of the ADP-ribosylation of (a) G-protein(s) as catalyzed by pertussis toxin was found in the mem- 
brane extract of rat liver. The inhibitor activity was found in the fractions of DEAE-Sephacel column chromatography 
at 50-120 mM NaCI. The inhibitor activity is not due to the degradation of NAD nor to the reverse reaction of pertussis 
toxin (removal of incorporated ADP-ribose). The present result suggests the presence of an endogenous inhibitor of the 
ADP-ribosylation reaction of (a) G-protein(s). 
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1. INTRODUCTION 
Pertussis toxin specifically catalyzes the mono- 
ADP ribosylation of the cysteine residue of several 
GTP-binding proteins (Gi, G,, transducin, etc.) 
[l-5] and leads to the functional uncoupling with 
the receptors. Thus, pertussis toxin has been wide- 
ly used as a powerful tool to demonstrate the in- 
volvement of such toxin-sensitive G-proteins in the 
physiological responses of the eukaryotic cells. 
Recently, the comparable ADP-ribosyltransferase 
activity to pertussis toxin has been found en- 
dogenously in eukaryotic cell [6] and has been con- 
sidered to regulate the signal transduction 
mechanism in vivo. However, if the endogenous 
ADP-ribosyltransferase constitutively modifies the 
function of G-proteins, it will cause the loss of the 
responses for the receptor stimulation. Thus, to 
elucidate the physiological importance of the en- 
dogenous ADP-ribosylation activity, it is necessary 
to identify its endogenous inhibitor or activator. 
In this context, we have started to investigate the 
endogenous inhibitor activity of the ADP- 
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ribosylation of the G-protein(s) as catalyzed by 
pertussis toxin. The present study shows the 
presence of such inhibitor activity in the membrane 
extract of rat liver that is distinct from NAD 
degradation activity and also from removal activi- 
ty of the incorporated ADP-ribose. 
2. MATERIALS AND METHODS 
Liver was taken from two adult male Sprague-Dawley rats 
(200-300 g). Membrane was prepared essentially according to 
[2] and suspended in 50 ml of buffer A (20 mM Tris-HCI, pH 
8.0, 1 mM EDTA, 1 mM dithiothreitol, 0.1 mM 
phenylmethylsulfonyl fluoride, 1% sodium cholate) and stirred 
on ice for 60 min. The suspension was centrifuged at 150000 x 
g for 60 min. The supernatant (40 ml) was used as membrane 
extract in the following step. The assay mixture for the inhibitor 
activity contained all the components for the ADP-ribosylation 
of G-proteins as catalyzed by pertussis toxin. 50 pl of the mix- 
ture contained final concentrations of the following: 40 mM 
Tris-HCI, pH 8.0, 5 mM thymidine, 20 mM dithiothreitol, 
0.5 mM L-cu-dimyristoyl phosphatidylcholine, 20 mM isoni- 
cotinic acid hydrazide, 5 PM GTP, 1 PM [j’P]NAD (l-20 Ci/ 
mmol), 300 fig/ml of partially purified G-protein fraction from 
bovine brain [2], and 8 pg/ml df pertussis toxin (Seikagakyu 
Kogyo Co.) previously activated by 50 mM dithiothreitol, 
1 mM ATP for 15 min at 30°C. To measure the inhibitor activi- 
ty, 5 ~1 of sample was added to 50 ~1 of the assay mixture at the 
beginning of the reaction. As for the control experiment, the 
whole assay mixture was used without adding any other compo- 
nent. After incubation at 30°C. the reaction was terminated by 
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the addition of 0.5 ml of 4% sodium dodecyl sulfate (SDS). The 
radioactivity incorporated to the protein fraction was measured 
according to [2]. 
3. RESULTS 
3.1. Inhibitor activity of the ADP-ribosylation of 
(a) G-protein(s) as catalyzed by pertussis 
toxin 
Membrane extract of rat liver was applied to a 
DEAE-Sephacel column (2 x 30 cm) equilibrated 
with buffer A. The radioactivity incorporated by 
pertussis toxin from [32P]NAD to the G-protein 
fraction was measured in the presence of each 
eluted fraction. As shown in fig.1, fractions 45 to 
55 contained inhibitor activity of the ADP- 
ribosylation and were used in the following ex- 
periments. The reaction product was analyzed by 
12.5% SDS-polyacrylamide gel electrophoresis ac- 
cording to Laemmli [7] and its autoradiogram is 
shown in fig.2. By the addition of the DEAE- 
Sephacel fraction, the ADP-ribosylation of about 
40 kDa species was completely inhibited. This in- 
dicates that the DEAE-Sephacel fraction inhibits 
the ADP-ribosylation of a-subunit of G-protein as 
catalyzed by pertussis toxin. 
3.2. Inhibitor activity is not due to the 
degradation of NAD 
It is well known that rat liver cytosol is a rich 
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Fig.l. DEAE-Sephacel column chromatography of rat liver 
membrane extract. Elution was performed with 150 ml of 
buffer A and then with 500 ml of a linear gradient of NaCl 
(from 0 to 300 mM). Fractions of 6 ml were collected. The 
radioactivity as incorporated in the ADP-ribosylation reaction 
for 3 h is shown by the relative value to that obtained in the 
control experiment (0). Absorbance at 280 nm is shown with a 
solid line and the concentration of NaCl with a broken line. 
Fig.2. Autoradiogram of SDS-polyacrylamide gel electro- 
phoresis of the 32P-labeled ADP-ribosylation product in the 
absence (1) and presence (2,3) of the DEAE-Sephacel fraction. 
In lane 3, G-protein fraction was omitted from the assay 
mixture. 
source of phosphodiesterase that degradates NAD 
as well as DNA and RNA [8]. In addition, Neer et 
al. [9] reported that the ADP-ribosylation as 
catalyzed by cholera toxin was inhibited by the 
presence of NAD-glycohydrolase activity in bovine 
brain. Therefore, to examine the degradation ac- 
tivity of NAD in DEAE-Sephacel fraction, the 
assay mixture of the ADP-ribosylation was ana- 
lyzed by paper chromatography. The degradation 
activity of NAD will convert the 32P-labelled 
species from [w~~P]NAD to [~u-~~P]AMP in the 
case of phosphodiesterase or to [Lu-32P]ADP-ribose 
in the case of NAD-glycohydrolase. As shown in 
fig.3, there was no apparent difference between the 
chromatographic patterns obtained in the presence 
and absence of the DEAE-Sephacel fraction. The 
major 32P-labelled species in the reaction mixture 
after the incubation was found to be NAD in both 
cases. Therefore the inhibitor activity in the frac- 
tions as eluted from DEAE-Sephacel cannot be ex- 
plained by the degradation of NAD. 
3.3. Inhibitor activity is not mediated by the 
removal of incorporated ADP-ribose 
Fig.4 shows the time course of the ADP- 
ribosylation as catalyzed by pertussis toxin. In the 
presence of the DEAE-Sephacel fraction, the 
plateau level was lowered, while the time required 
for obtaining the plateau level was almost un- 
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Fig.3. Autoradiogram of paper chromatography of 
[a-“PINAD in the assay mixture of ADP-ribosylation before 
(1) and after (2) incubation, and after incubation in the presence 
of the DEAE-Sephacel fraction (3). The solvent system was 1 M 
ammonium acetate (pH 5.0)/95% ethanol (3:7, v/v) [ll]. 
changed. If the ADP-ribosyltransferase activity of 
pertussis toxin is diminished by the inhibitor activi- 
ty, the time required for the plateau level will be in- 
creased. Thus it is suggested that the inhibitor 
activity in the DEAE-Sephacel fraction does not 
affect the pertussis toxin activity. The lowered 
plateau level can be explained in two different 
ways. One is the removal of incorporated ADP- 
ribose from G-protein(s) and the other is the 
decrease in the substrate concentration. To ex- 
amine the former possibility, the DEAE-Sephacel 
fraction was added after the ADP-ribosylation 
reaction took place (fig.5). The specific activity of 
NAD was reduced as low as l/1000, so that the f- 
fect of the further ADP-ribosylation was negligi- 
ble. The results showed that the DEAE-Sephacel 
fraction had no effect on the incorporated radioac- 
tivity of the ADP-ribosylated protein. Therefore, 
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Fig.4. ADP-ribosylation time course in the absence (0) and 
presence (=) of the DEAE-Sephacel fraction. The incorporated 
radioactivity per 50 pl of the assay mixture is shown. 
the lowered plateau level is not due to the removal 
of ADP-ribose. Thus the inhibitor activity is 
probably mediated by the decrease in substrate 
concentration. As described previously, the in- 
hibitor activity is not due to the degradation of 
NAD. Therefore we assume that the target of the 
inhibitor activity is (a) G-protein(s). Further in- 
vestigation is necessary to elucidate the precise 
mechanism of the inhibition. 
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Fig.5. Effect of the DEAE-Sephacel fraction on the 
incorporated radioactivity by pertussis toxin. The ADP- 
ribosylation assay mixture containing bovine G-protein fraction 
was previously incubated for 3 h and then the DEAE-Sephacel 
fraction was added together with NAD to a final concentration 
of 1 mM. The radioactivity at T = 0 is taken as 100%. 
29 
Volume 234, number 1 FEBS LETTERS July 1988 
4. DISCUSSION 
In the present study, we have found the inhibitor 
activity of the ADP-ribosylation of (a) G- 
protein(s) as catalyzed by pertussis toxin from the 
membrane extract of rat liver. The present study 
suggests the presence of an endogenous inhibitor 
of the cellular ADP-ribosyltransferase in rat liver. 
The ADP-ribosylation activity comparable to per- 
tussis toxin in rat liver was previously proposed by 
Itoh et al. [ll]. The physiological roles of the en- 
dogenous ADP-ribosylation will be elucidated by 
the combined study of endogenous ADP-ribosyl- 
transferase and its endogenous inhibitor. 
As mentioned in section 1, the sensitivity to per- 
tussis toxin has been widely used to classify the 
physiological responses. If the response was not af- 
fected by the pertussis toxin treatment in vivo, it 
was concluded that the response was not mediated 
by the pertussis toxin-sensitive G-protein. This 
conclusion is based on the assumption that there is 
no endogenous inhibitor of pertussis toxin. 
However, as reported here, we have shown the 
presence of the endogenous inhibitor activity of 
pertussis toxin. Accordingly, it is possible that 
some pertussis toxin-sensitive G-proteins are in- 
volved in the physiological responses without being 
modified by the pertussis toxin treatment. 
The purification and the characterization of the 
inhibitor found in the present study are now in 
progress in our laboratory. It is expected that the 
endogenous inhibitor is one of the members that 
regulate the signal transduction mechanism. 
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